CONDITION
Evidence-Based Compounds for Osteoporosis
Osteoporosis involves an imbalance between osteoblast-mediated bone formation and osteoclast-mediated resorption, resulting in reduced bone mineral density and fracture risk. Compounds with clinical evidence for increasing bone density, improving bone quality markers, and supporting collagen matrix formation are ranked below.
Top 9 Compounds — Ranked by Evidence
Weighted ranking: BiohacksAI discovery score · pathway overlap · PubMed study count
Ranking Methodology
Compounds are ranked using a four-signal weighted model: BiohacksAI discovery score (cross-study convergence across targets), target match (direct overlap with VDR, RUNX2, TNFSF11 and related targets — highest differentiating signal), pathway overlap with CALCIUM SIGNALING and INFLAMMATION pathways, and PubMed study count (log-scaled). Clinical drugs are excluded.
Key Biological Targets
Related Health Goals
Related Conditions
This page presents computational analysis of published research from PubMed/NCBI, BindingDB, and Reactome. Rankings are based on BiohacksAI discovery score, pathway overlap, and study count. This is not medical advice — consult a healthcare professional before starting any supplement.
Browse all compounds · Biological pathways · Molecular targets · All conditions
© Organiq Sweden AB · Patent pending EVE-PAT-2026-001